23Strands is combining advances in artificial intelligence (AI) with whole genomic sequencing to develop suitable treatments and alleviate the suffering of health complications relating to genetic disorders, such as haemochromatosis. Individuals suffering from haemochromatosis absorb an excessive amount of iron from their diet, leading to organ damage and premature death. 23Strands can also conduct extensive gene expression analysis, which reveals possible targets for precision drug therapy and evaluates the effectiveness of responses to chemotherapy drugs. 23Strands’ goal of addressing genetic diseases is central to its focus on personalised medicine.